Showing results (91-100 of 223) with videos related to
Sort By:
Pageof 23
Headache|December 30, 2025
Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trialNathaniel M Schuster, Mark S Wallace, Thomas D Marcotte, et al.Clinical Therapeutics|February 8, 2022
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2Vincent Martin, A Jim Nagy, Marina Janelidze, et al.Headache|October 17, 2017
AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical TrialRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.The Journal of Headache and Pain|February 26, 2024
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J Starling, Roger Cady, Dawn C Buse, et al.Journal of Patient-Reported Outcomes|April 4, 2023
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraineJanet H Ford, Wenyu Ye, David W Ayer, et al.Headache|July 10, 2024
Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional studyManjit Matharu, Zaza Katsarava, Dawn C Buse, et al.Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled TrialNathaniel M Schuster, Mark S Wallace, Thomas D Marcotte, et al.Scandinavian Journal of Pain|February 5, 2021
Health-related quality of life in tension-type headache: a population-based studySait Ashina, Dawn C Buse, Jakob B Bjorner, et al.Journal of Patient-Reported Outcomes|December 18, 2021
Combining patient reported outcomes and EHR data to understand population level treatment needs: correcting for selection bias in the migraine signature studyWalter F Stewart, Xiaowei Yan, Alice Pressman, et al.Pain and Therapy|March 13, 2024
Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive ResponseDawn C Buse, Lynda J Krasenbaum, Michael J Seminerio, et al.Pageof 23